KRT18 and metabolic dysfunction-associated steatohepatitis: Finally, in 101 obese patients with NASH, a biomarker panel comprised of cleaved cytokeratin 18 (CK-18), adiponectin, and resistin had 95% sensitivity and 70% specificity for diagnosis [78].